Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2000The Journal of Clinical Endocrinology & MetabolismOpen Access

Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

DBDennis M. BlackUniversité Claude Bernard Lyon 1DTDesmond ThompsonUniversity of North TexasDBDouglas C. BauerStevens Institute of Technology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Black et al. (2000) studied this question.

synapsesocial.com/papers/6a7d8f8533dcb27c99cb4cfbhttps://doi.org/10.1210/jcem.85.11.6953
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>1999 · 3,386 citations
  2. 2Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>1998 · 2,291 citations
  3. 3Vertebral fracture assessment using a semiquantitative technique1993 · 3,715 citations
  4. 4Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women1994 · 679 citations